ID Age Onset yrs DMA MMSE 1 29 7 IFNβ i.m. 28 2 28 6 IFNβ i.m. 28 3 42 9 IFNβ s.c. 30 4 41 5 IFNβ s.c. 29 5 28 5 - 29 6 29 3 IFNβ i.m. 29 7 44 22 - 29 8 42 14 IFNβ s.c. 29 9 49 6 IFNβ i.m. 29 10 39 8 IFNβ i.m. 29 11 33 15 - 29 12 40 5 IFNβ i.m. 29 13 46 2 -  30 14 30 5 glatiramer acetate 30 15 44 8 IFNβ i.m. 30 16 43 4 IFNβ s.c. 29 17 52 15 IFNβ s.c. 29 18 37 13 -  29 19 55 13 glatiramer acetate 30 20 33 7 -  30 21 44 7 IFNβ i.m. 29 22 39 14 IFNβ s.c. 30 23 27 9 IFNβ i.m. 28 24 42 17 glatiramer acetate 29 25 43 22 IFNβ i.m. 30 26 20 2 IFNβ i.m. 29 27 43 28 -  29 28 29 11 IFNβ s.c. 30 29 36 12 IFNβ i.m. 30 30 46 3 IFNβ s.c. 30 31 32 9 -  29 32 36 2 glatiramer acetate 29 33 33 10 IFNβ i.m. 29 34 34 9 IFNβ s.c. 29 35 30 3 IFNβ i.m. 30 36 38 13 IFNβ s.c. 29 37 37 7 IFNβ i.m. 28 38 35 7 IFNβ s.c. 30 39 52 16 IFNβ i.m. 28 40 51 22 IFNβ i.m. 29 41 37 20 IFNβ s.c. 30 42 30 1 IFNβ i.m. 30 43 27 1 IFNβ s.c. 30 44 55 9 glatiramer acetate 29 45 19 2 IFNβ i.m. 30 46 42 6 glatiramer acetate 29 47 23 6 IFNβ s.c. 30 48 42 10 IFNβ s.c. 29 49 31 2 IFNβ i.m. 30 50 37 9 IFNβ i.m. 29 DMA = Disease Modifyng Agent; IFNβ i.m = interferon beta into the muscle; IFNβ s.c = interferon beta subcutaneous.

Table 1 Demographical, pharmacological and cognitive preservation data for the 50 females RRMS patients participating in the study.